Method and kit for detecting presence and/or amount of bacteria of enterobacteriaceae in food/drink sample, environmental sample, or biological sample
US-2024069022-A1 · Feb 29, 2024 · US
US11987618B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11987618-B2 |
| Application number | US-202117141477-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 5, 2021 |
| Priority date | May 31, 2012 |
| Publication date | May 21, 2024 |
| Grant date | May 21, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Single-domain antibodies (SAbs) against three Yersinia pestis surface proteins (LcrV, YscF, and F1), nucleic acid sequences encoding the SAbs, and polypeptides comprising two or more SAbs capable of recognizing two or more epitopes and/or antigens. The present invention further includes methods for preventing or treating Y. pestis infections in a patient; methods for detecting and/or diagnosing Y. pestis infections; and devices and methods for identifying and/or detecting Y. pestis on a surface and/or in an environment.
Opening claim text (preview).
What is claimed is: 1. A single-domain antibody against Yersinia pestis ( Y. pestis ) LcrV protein comprising: a first framing region (“FR”) sequence comprising SEQ ID No:97 or SEQ ID No:98; a first complementarity determining region (“CDR”) sequence comprising SEQ ID No:22; a second FR sequence comprising SEQ ID No:116, the first CDR sequence being positioned between the first FR sequence and the second FR sequence; a second CDR sequence comprising SEQ ID No:49; a third FR sequence comprising SEQ ID No: 141, the second CDR sequence being positioned between the second FR sequence and the third FR sequence; a third CDR sequence comprising SEQ ID No.73; and a fourth FR sequence comprising SEQ ID No:148, the third CDR sequence being positioned between the third FR sequence and the fourth FR sequence. 2. The single-domain antibody of claim 1 , further comprising: at least one of a protein tag, a protein domain tag, or a chemical tag.
Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G) · CPC title
from camelids, e.g. camel, llama or dromedary · CPC title
Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody® · CPC title
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.